Applications of (1S,2R)-1-Phenyl-2-(1-Pyrrolidinyl)Propan-1-ol in Industrial Manufacturing

As a direct manufacturer, we supply (1S,2R)-1-Phenyl-2-(1-Pyrrolidinyl)Propan-1-ol to a range of downstream sectors that require precise enantiopure intermediates. Our participation in end-user industrial processes guarantees reliable integration with international compliance, critical for scalable, regulated production. Below are several main industrial applications based on verified downstream practices using this chiral compound.

1. Active Pharmaceutical Ingredient (API) Intermediate for Central Nervous System Stimulants

(1S,2R)-1-Phenyl-2-(1-Pyrrolidinyl)Propan-1-ol functions as a key chiral intermediate in the synthesis of pharmaceutical compounds targeting attention deficit and related disorders. Formulators depend on its defined stereochemistry for consistent pharmacological profiles. Raw material quality and traceability remain essential for users required to pass stringent regulatory inspections during the drug approval process, necessitating full batch traceability and enantiomeric excess validation from raw intermediate suppliers.

Industry compliance standards

• Current Good Manufacturing Practices (cGMP/ICH Q7)
• European Pharmacopoeia (Ph. Eur.) monographs for substances and intermediates
• United States Pharmacopeia (USP) requirements for chiral intermediates
• Drug Master File (DMF) registration and audit traceability

Typical usage ratio

• Employed at 0.9–1.2 molar equivalents relative to downstream reactants; slight excess may be used depending on conversion and purity targets

Downstream process integration

• Added in chiral alkylation or reductive amination stages after initial condensation, followed by purification and crystallization prior to final API synthesis

Final product types

• Pharmaceutical central nervous system stimulants (prescription drugs)
• Investigational New Drugs (INDs) requiring chiral precursors
• Generic formulations based on reference listed drugs (RLD) standards

2. Fine Chemical Synthesis for Enantiopure Building Blocks

Specialty fine chemical manufacturers utilize this chiral alcohol to construct advanced intermediates and specialty building blocks, particularly where the stereocenter must be strictly conserved. Customers require analytical documentation demonstrating the enantiomeric purity, often involving chiral HPLC or NMR, to fulfill contractual obligations to downstream buyers.

Industry compliance standards

• ISO 9001:2015 Quality Management System
• REACH (EC 1907/2006) Substance Registration for imported/exported intermediates in the EU
• Responsible Care® management framework for chemical manufacturing
• Corporate social responsibility (CSR) reporting and environmental disclosure protocols

Typical usage ratio

• Used at 0.8–1.5 molar equivalents; ratio depends on subsequent functional group manipulations, with slight excess ensuring high conversion rates

Downstream process integration

• Charged after selection of solvents and base in enantioselective coupling reactions; chiral integrity monitored by in-process analysis prior to downstream transformation steps

Final product types

• Custom chiral building blocks for pharma and agrochemical R&D
• Intermediates for custom synthesis contracts
• Precursors for next-generation ligand development

3. Research-Grade Chemical Supply for Analytical and Synthetic Laboratories

Academic and contract research organizations require small- to medium-quantity lots of this compound for method development and stereoselective synthesis studies. Accurate certificate of analysis, detailed impurity profiling, and origin documentation are routinely requested during the ordering and QC process, as laboratory protocols may directly influence peer-reviewed publications and intellectual property filings.

Industry compliance standards

• ACS Reagent Grade Specifications
• GLP (Good Laboratory Practice) compliance for research supply chains
• ISO/IEC 17025 testing methodology for chemical reference materials
• Material Safety Data Sheet (MSDS/GHS) documentation aligned to global standards

Typical usage ratio

• Applied at 0.5–1.0 mmol scale per synthesis batch for screening; can scale up to gram-quantities for pilot reactions depending on protocol design

Downstream process integration

• Dosed during comparative synthesis trials, screening of novel reaction methodologies, and calibration of preparative chromatography procedures

Final product types

• Reference standards for analytical method validation
• Small-batch enantiopure test compounds for academic publications
• Lead structure candidates for medicinal chemistry optimization

4. Chiral Auxiliary in Asymmetric Synthesis Development

Chemical process innovation groups and asymmetric synthesis specialists deploy this material as a chiral auxiliary or a resolving agent. Its defined stereochemistry ensures reliable induction of chirality in target molecules, reducing the need for racemate separation and increasing process yields. End-users demand batch-specific spectral data and process documentation, especially for pilot-scale route scouting and subsequent transfer to technical-scale production.

Industry compliance standards

• Process validation protocols as per ICH Q11 (Development and Manufacture of Drug Substances)
• CAPA (Corrective and Preventive Action) requirements under ISO 13485 for auxiliary reagents
• Synthetic route documentation for technology transfer under CMC (Chemistry, Manufacturing, and Controls)
• Environmental permitting under local chemical processing regulations

Typical usage ratio

• Integrated at 0.6–1.3 molar equivalents in asymmetric transformation steps; ratio optimized during scale-up to balance cost-efficiency and yield

Downstream process integration

• Introduced as a chiral pool starting material or as an auxiliary during key enantioselective transformations, followed by downstream cleavage or recycling depending on process design

Final product types

• Enantioenriched pharmaceutical intermediates
• Specialty chemicals for fine chemical catalog supply
• Scale-up samples for technology transfer to commercial production facilities